AUG 8, 2026 · JOURNAL ARTICLE
Optimal timing of post-therapeutic [131I]NaI whole-body scintigraphy in predominantly low- and intermediate-risk differentiated thyroid cancer: a secondary analysis of prospectively acquired data and a structured literature review
BMC Medical Imaging
A well-designed secondary analysis of prospectively acquired imaging data with independent expert assessment and rigorous statistical methods, but limited to a single-centre cohort of 35 patients evaluating a surrogate imaging quality endpoint rather than clinical outcomes.
Reported
Criteria-based score at 24 h39.52 (95% CI, 38.62–40.43)
Criteria-based score at 48 h34.79
P-value (24 h vs 48 h)0.091